Showing 1 - 18 results of 18 for search 'Antonio Llombart-Cussac', query time: 0.13s Refine Results
  1. 1
    Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
    by Christian Jackisch, Antonio Llombart-Cussac
    Published 2014-09-01
    Get full text
    Article
  2. 2
    The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”
    Get full text
    Article
  3. 3
    Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality.
    Get full text
    Article
  4. 4
    Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
    Get full text
    Article
  5. 5
    The role of CDK4/6 inhibitors in early breast cancer
    Get full text
    Article
  6. 6
    The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
    Get full text
    Article
  7. 7
    Nobody dares stopping clinical research, not even COVID-19
    Get full text
    Article
  8. 8
    Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population
    Get full text
    Article
  9. 9
    Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
    Get full text
    Article
  10. 10
    Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.
    Get full text
    Article
  11. 11
    Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design
    Get full text
    Article
  12. 12
    Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial
    Get full text
    Article
  13. 13
    Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
    Get full text
    Article
  14. 14
    Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
    Get full text
    Article
  15. 15
    Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype
    Get full text
    Article
  16. 16
    Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
    Get full text
    Article
  17. 17
    NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
    Get full text
    Article
  18. 18
    Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search